Agios Pharmaceuticals Inc Bruttó árrés
Mi az Agios Pharmaceuticals Inc Bruttó árrés?
A Bruttó árrés az Agios Pharmaceuticals Inc - 89.26%
Mi a Bruttó árrés meghatározása?
A bruttó árrés az árbevétel és az eladott áruk költségének különbsége, osztva bevételekkel, és százalékban kifejezve.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Bruttó árrés a Health Care szektor a NASDAQ-on cégekben a Agios Pharmaceuticals Inc -hoz képest
Mit csinál Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
bruttó árrés -hoz hasonló cégek Agios Pharmaceuticals Inc
- Darktrace plc nak Bruttó árrés 89.21% van
- Proactis Plc nak Bruttó árrés 89.23% van
- Tian An Australia nak Bruttó árrés 89.23% van
- Bajaj Finance nak Bruttó árrés 89.24% van
- Nirlon nak Bruttó árrés 89.25% van
- Ackroo nak Bruttó árrés 89.26% van
- Agios Pharmaceuticals Inc nak Bruttó árrés 89.26% van
- UroGen Pharma nak Bruttó árrés 89.27% van
- SREI Infrastructure Finance nak Bruttó árrés 89.29% van
- KemPharm nak Bruttó árrés 89.29% van
- Beijing Baolande Software nak Bruttó árrés 89.31% van
- BF Utilities nak Bruttó árrés 89.33% van
- Doximity nak Bruttó árrés 89.34% van